Announcement on Convening the 2025 Semi-annual Performance Briefing
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Convening the 2025 Semi-annual Performance Briefing
Filed with SSE · · 3 pages · Chinese
Release
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited on 6ix
Earlier from Guangzhou Baiyunshan Pharmaceutical
- Announcement on the Completion of Private Fund Filing and Progress of Related Party Transactions
- Full Text of 2025 Semi-annual Report
- Announcement on Participation in the Investment and Establishment of Equity Investment Fund and Related Party Transactions
- Announcement on Subsidiary Obtaining Drug Supplementary Application Approval
- Announcement on Resolution of the 26th Meeting of the 9th Board of Directors
Later from Guangzhou Baiyunshan Pharmaceutical
- Announcement on Subsidiary Obtaining Approval for Marketing of Chemical APIs
- Notice on Convening the 2nd Extraordinary General Meeting in 2025
- Announcement on Subsidiary’s Drug Entering Key Clinical Trials
- Announcement on Subsidiary’s Drug Entering Phase II Clinical Trials
- Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025
Follow Guangzhou Baiyunshan Pharmaceutical into a list and get an email when it puts out news.
Follow Guangzhou Baiyunshan Pharmaceutical